COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction
Status:
Active, not recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This study evaluates the benefit of colchicine on induced denervation after myocardial
infarction. Patients who have suffered a documented De Novo myocardial infarction and
completed a revascularization procedure will receive either colchicine on top of standard
therapy, compared to standard therapy alone (1:1 allocation ratio). Colchicine 1mg (or 0.5mg)
will be initiated within 48h after percutaneous revascularization and prescribed for one
month.